Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

While designed to address the nighttime interrupted breathing characteristic of OSA, CPAP has the added potential of helping improve your asthma symptoms if you have both conditions. If you have ...

Apr. 10, 2024 — One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has ... Feb. 29, 2024 ...

The main patent on Advair (fluticasone+salmeterol ... Wixela Inhub is indicated for the twice daily treatment of asthma in patients age four and older not adequately controlled on long-term ...

Nasal sprays are key in managing congestion, using saline for moisture, decongestants for swelling, and steroids for deeper ...

Dr Lutz Beckert, Professor of Medicine at the University of Otago and a respiratory specialist with Te Whatu Ora Canterbury says the new COPD Clinical Care Standard, which was launched last month by ...